Phase II Study of Lutetium-177-labeled Anti Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.
Abstract
Data di Pubblicazione:
2015
Tipologia CRIS:
1.5 Abstract in rivista
Elenco autori:
Muselaers, Chj; Boers-Sonderen, Mj; van Oostenbrugge, Tj; Boerman, Oc; Desar, Ime; Stillebroer, Ab; Mulder, Sf; van Herpen, Cml; Langenhuijsen, Jf; Oosterwijk, E; Mulders, Pfa; Oyen, W
Link alla scheda completa:
Pubblicato in: